改革固体瘤治疗:较小格式抗体-药物结合物的新兴潜力
Xiaojie Ma1, Mingkai Wang1, Tianlei Ying1,2
1MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Antibody therapeutics
|April 3, 2024
概括
较小的抗体碎片通过改善瘤透来增强抗体-药物合物 (ADCs) 用于固体瘤治疗. 本综述探讨了使用这些片段的新型ADC设计,如单域抗体,以获得更好的治疗结果.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗体-药物合物 (ADC) 已在治疗恶性瘤方面表现出显著的疗效,有16种已批准的疗法.
- 在固体瘤中限制ADC临床使用的一个主要挑战是瘤透率低于最佳水平.
研究的目的:
- 审查使用较小的抗体格式开发抗体-药物结合物的进展.
- 突出应用单域抗体在新的ADC设计中,以改善固体瘤治疗.
主要方法:
- 专注于抗体碎片-药物合物,其分子大小减少 (约6到80kDa).
- 强调单域抗体作为新型ADC设计的关键组成部分.
- 讨论优化临床翻译的策略,包括延长半衰期和增强内部化.
主要成果:
- 与传统抗体相比,小型化的抗体碎片提供了更好的瘤透.
- 抗体片段-药物联体证明了对细胞毒性剂的有效输送的承诺.
- 工程抗体格式可以在固体瘤中带来优异的治疗结果.
结论:
- 较小的抗体格式,特别是单域抗体,对于克服ADC瘤透限制至关重要.
- 优化抗体片段与药物合物具有增强癌症治疗的巨大潜力.
- 需要进一步的策略来加速临床转化并最大限度地提高治疗效益.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523


